ETF Managers Group’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-56
| Closed | -$255K | – | 737 |
|
|
2021
Q3 | $255K | Sell |
56
-4
| -7% | -$18.2K | ﹤0.01% | 602 |
|
|
2021
Q2 | $419K | Sell |
60
-19
| -24% | -$133K | 0.01% | 557 |
|
|
2021
Q1 | $562K | Buy |
79
+14
| +22% | +$99.6K | 0.01% | 397 |
|
|
2020
Q4 | $553K | Buy |
65
+1
| +2% | +$8.51K | 0.01% | 325 |
|
|
2020
Q3 | $658K | Buy |
64
+5
| +8% | +$51.4K | 0.02% | 264 |
|
|
2020
Q2 | $417K | Sell |
59
-3
| -5% | -$21.2K | 0.01% | 290 |
|
|
2020
Q1 | $271K | Buy |
62
+6
| +11% | +$26.2K | 0.01% | 334 |
|
|
2019
Q4 | $337K | Buy |
56
+6
| +12% | +$36.1K | 0.01% | 327 |
|
|
2019
Q3 | $361K | Buy |
50
+4
| +9% | +$28.9K | 0.01% | 289 |
|
|
2019
Q2 | $299K | Buy |
46
+4
| +10% | +$26K | 0.01% | 288 |
|
|
2019
Q1 | $347K | Sell |
42
-5
| -11% | -$41.3K | 0.02% | 253 |
|
|
2018
Q4 | $260K | Buy |
47
+13
| +38% | +$71.9K | 0.01% | 275 |
|
|
2018
Q3 | $301K | Buy |
+34
| New | +$301K | 0.01% | 235 |
|
|
2018
Q2 | – | Sell |
-26
| Closed | -$130K | – | 573 |
|
|
2018
Q1 | $130K | Buy |
26
+4
| +18% | +$20K | 0.01% | 247 |
|
|
2017
Q4 | $112K | Buy |
22
+11
| +100% | +$56K | 0.01% | 231 |
|
|
2017
Q3 | $118K | Buy |
11
+1
| +10% | +$10.7K | 0.01% | 136 |
|
|
2017
Q2 | $88K | Buy |
+10
| New | +$88K | 0.01% | 196 |
|